329 related articles for article (PubMed ID: 27493347)
1. Chronic immune thrombocytopenia in a child responding only to thrombopoietin receptor agonist.
Osman ME
Sudan J Paediatr; 2012; 12(2):60-4. PubMed ID: 27493347
[TBL] [Abstract][Full Text] [Related]
2. Romiplostim in chronic immune thrombocytopenic purpura.
Cersosimo RJ
Clin Ther; 2009 Sep; 31(9):1887-907. PubMed ID: 19843480
[TBL] [Abstract][Full Text] [Related]
3. Use of romiplostim in a hemodialysis patient with primary immune thrombocytopenia.
Al-Jafar H; Giagounidis A; El-Rashaid K; Al-Ali M; Hakim AA
Ann Pharmacother; 2012 Nov; 46(11):e31. PubMed ID: 23115229
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic approach and treatment of immune thrombocytopenia in adults].
Kolonić SO; Patekar MB; Milunović V
Acta Med Croatica; 2013 Mar; 67(1):3-11. PubMed ID: 24279250
[TBL] [Abstract][Full Text] [Related]
5. Childhood immune thrombocytopenia: Clinical presentation and management.
Faki Osman ME
Sudan J Paediatr; 2012; 12(1):27-39. PubMed ID: 27493327
[TBL] [Abstract][Full Text] [Related]
6. Romiplostim-related myelofibrosis in refractory primary immune thrombocytopenia: A Case report.
Kim HY; Park SW; Kim JH; Kang JH; Lee WS; Song HN
Medicine (Baltimore); 2019 Jun; 98(25):e15882. PubMed ID: 31232923
[TBL] [Abstract][Full Text] [Related]
7. Thrombopoietin receptor agonists in refractory immune thrombocytopenia: differential responses to eltrombopag and romiplostim: a case report and possible explanations.
Aoki T; Harada Y; Matsubara E; Suzuki T; Oyama T; Kasai M; Uchida T; Ogura M
J Clin Pharm Ther; 2012 Dec; 37(6):729-32. PubMed ID: 22583038
[TBL] [Abstract][Full Text] [Related]
8. Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study.
Zaja F; Barcellini W; Cantoni S; Carpenedo M; Caparrotti G; Carrai V; Di Renzo N; Santoro C; Di Nicola M; Veneri D; Simonetti F; Liberati AM; Ferla V; Paoloni F; Crea E; Volpetti S; Tuniz E; Fanin R
Am J Hematol; 2016 May; 91(5):E293-5. PubMed ID: 26910388
[TBL] [Abstract][Full Text] [Related]
9. Severe romiplostim-induced rebound thrombocytopenia after splenectomy for refractory ITP.
Choe MJ; Packer CD
Ann Pharmacother; 2015 Jan; 49(1):140-4. PubMed ID: 25325908
[TBL] [Abstract][Full Text] [Related]
10. Role of romiplostim in splenectomized and nonsplenectomized patients with immune thrombocytopenia.
Perdomo J
Immunotargets Ther; 2016; 5():1-7. PubMed ID: 27529057
[TBL] [Abstract][Full Text] [Related]
11. Steroid-Refractory Chronic Idiopathic Thrombocytopenic Purpura Responding to Combination Therapy With Eltrombopag and Rituximab.
Ahmed M; Yassin MA; Abdelmahmuod E
Cureus; 2020 Sep; 12(9):e10305. PubMed ID: 33052268
[TBL] [Abstract][Full Text] [Related]
12. The role of romiplostim for pediatric patients with immune thrombocytopenia.
Al-Samkari H; Grace RF; Kuter DJ
Ther Adv Hematol; 2020; 11():2040620720912992. PubMed ID: 32523658
[TBL] [Abstract][Full Text] [Related]
13. Effect of a thrombopoietin receptor agonist on use of intravenous immune globulin in patients with immune thrombocytopenia.
Zeller MP; Heddle NM; Kelton JG; Hamilton K; Wang G; Sholapur N; Carruthers J; Hsia C; Blais N; Toltl L; Hamm C; Pearson MA; Arnold DM
Transfusion; 2016 Jan; 56(1):73-9. PubMed ID: 26400824
[TBL] [Abstract][Full Text] [Related]
14. Is there any Role for Splenectomy in Adulthood Onset Chronic Immun e Thrombocytopenia in the Era of TPO Receptors Agonists? A Critic al Overview.
Vibor M; Rogulj IM; Ostojic SK
Cardiovasc Hematol Disord Drug Targets; 2017 Jul; 17(1):38-51. PubMed ID: 28034281
[TBL] [Abstract][Full Text] [Related]
15. [Successful switching from eltrombopag to romiplostim in a pediatric patient with refractory chronic ITP].
Mori M; Kato M; Koh K; Hanada R
Rinsho Ketsueki; 2015 May; 56(5):511-3. PubMed ID: 26062675
[TBL] [Abstract][Full Text] [Related]
16. Successful early romiplostim use in a case of severe immune thrombocytopenia with critical carotid arterial injury.
Watanabe R; Tabayashi T; Tomikawa T; Sagawa M; Anan-Nemoto T; Kimura Y; Takahashi Y; Tokuhira M; Otaki S; Oi H; Sawano M; Sugiyama S; Kizaki M
Int J Hematol; 2017 Jan; 105(1):100-103. PubMed ID: 27709451
[TBL] [Abstract][Full Text] [Related]
17. Eltrombopag, a thrombopoietin- receptor agonist in the treatment of adult chronic immune thrombocytopenia: a review of the efficacy and safety profile.
Cheng G
Ther Adv Hematol; 2012 Jun; 3(3):155-64. PubMed ID: 23556122
[TBL] [Abstract][Full Text] [Related]
18. Use of the novel thrombopoietin receptor-agonist romiplostim, in combination with steroids and immunoglobulins for the increase of platelets prior to splenectomy, in refractory immune thrombocytopenia: a case report.
Sivera P; Ruella M; Gueli A; Hu H; Wade M; Tarella C
Blood Coagul Fibrinolysis; 2012 Jun; 23(4):331-4. PubMed ID: 22343685
[TBL] [Abstract][Full Text] [Related]
19. The use of thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): a "real life" retrospective multicenter experience of the Rete Ematologica Pugliese (REP).
Mazza P; Minoia C; Melpignano A; Polimeno G; Cascavilla N; Di Renzo N; Specchia G
Ann Hematol; 2016 Jan; 95(2):239-44. PubMed ID: 26596973
[TBL] [Abstract][Full Text] [Related]
20. Advances in Diagnosis and Treatments for Immune Thrombocytopenia.
Nomura S
Clin Med Insights Blood Disord; 2016; 9():15-22. PubMed ID: 27441004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]